GlassScriptPhysician profile
Wael Ghali
NPI 1467518118
$4,594.07
in general payments reported to CMS, 2019-2025
16 companies · $402 in 2025
The $402 reported for 2025 was more than what 88% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $739 · 2020: $438 · 2021: $628 · 2022: $1,257 · 2023: $536 · 2024: $594 · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,532.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,425.14 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $887.78 | 2019-2023 | Fasenra, Andexxa, Saphnelo |
| Janssen Scientific Affairs, LLC | $651.21 | 2021-2024 | Xarelto |
| Mallinckrodt Hospital Products INC. | $282.56 | 2024 | Terlivaz |
| Novartis Pharmaceuticals Corporation | $258.04 | 2019-2020 | |
| Abbvie INC. | $161.38 | 2021-2025 | |
| Janssen Biotech, INC. | $147.14 | 2025 | Simponi Aria, Tremfya |
| Pfizer INC. | $130.95 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $124.67 | 2022 | |
| Bioventus LLC | $122.64 | 2020 | |
| Ucb, INC. | $94.91 | 2025 | Bimzelx |
| Ipsen Biopharmaceuticals, INC | $93.77 | 2024 | Onivyde |
| Allergan, INC. | $70.92 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $63.42 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $60.69 | 2019-2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $18.85 | 2024 | Veklury |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wael Ghali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.